0001567619-19-000411.txt : 20190103
0001567619-19-000411.hdr.sgml : 20190103
20190103195340
ACCESSION NUMBER: 0001567619-19-000411
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vincent Mark D.
CENTRAL INDEX KEY: 0001761243
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32001
FILM NUMBER: 19507973
MAIL ADDRESS:
STREET 1: C/O APTOSE BIOSCIENCES INC.
STREET 2: 251 CONSUMERS ROAD, SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptose Biosciences Inc.
CENTRAL INDEX KEY: 0000882361
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 251 CONSUMERS ROAD
STREET 2: SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
BUSINESS PHONE: 647-479-9828
MAIL ADDRESS:
STREET 1: 251 CONSUMERS ROAD
STREET 2: SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
FORMER COMPANY:
FORMER CONFORMED NAME: Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.)
DATE OF NAME CHANGE: 20140905
FORMER COMPANY:
FORMER CONFORMED NAME: LORUS THERAPEUTICS INC
DATE OF NAME CHANGE: 19990308
FORMER COMPANY:
FORMER CONFORMED NAME: IMUTEC PHARMA INC
DATE OF NAME CHANGE: 19970113
4
1
doc1.xml
FORM 4
X0306
4
2019-01-02
0
0000882361
Aptose Biosciences Inc.
APTO
0001761243
Vincent Mark D.
C/O APTOSE BIOSCIENCES INC.
251 CONSUMERS ROAD, SUITE 1105
TORONTO
A6
M2J 4R3
ONTARIO, CANADA
1
0
0
0
Stock Options (Right to Buy)
1.91
2019-01-02
4
A
0
40000
0
A
2029-01-02
Common Stock
40000
40000
D
The exercise price reported above was converted from the Canadian exercise price of $2.60 using an exchange rate of 1.3600.
The options vest fully on the first anniversary of the grant.
/s/ Janet Clennett, as attorney-in-fact for Mark D. Vincent
2019-01-03